tacedinaline
Term · Oncology and biomedicine · MLC-T-ONC-016958
An orally bioavailable substituted benzamide derivative with potential antineoplastic activity. Tacedinaline inhibits histone deacetylation, which may result in histone hyperacetylation, followed by the induction of differentiation, the inhibition of cell proliferation, and apoptosis in susceptible tumor cell populations.
| Identifier | MLC-T-ONC-016958 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | acetyldinaline |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016958",
"term": "tacedinaline",
"field": "Oncology and biomedicine",
"definition": "An orally bioavailable substituted benzamide derivative with potential antineoplastic activity. Tacedinaline inhibits histone deacetylation, which may result in histone hyperacetylation, followed by the induction of differentiation, the inhibition of cell proliferation, and apoptosis in susceptible tumor cell populations.",
"synonyms": [
"acetyldinaline"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/tacedinaline/"
}
Record 15,934 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.